Early Detection and Diagnosis

You have full text access to this OnlineOpen article

Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma

  1. Ajay Matta1,2,†,
  2. Satyendra Chandra Tripathi3,†,
  3. Leroi V. DeSouza1,2,
  4. Jörg Grigull4,
  5. Jatinder Kaur3,
  6. Shyam Singh Chauhan3,
  7. Anurag Srivastava5,
  8. Alok Thakar6,
  9. Nootan Kumar Shukla7,
  10. Ritu Duggal8,
  11. Siddhartha DattaGupta9,
  12. Ranju Ralhan1,2,10,11,12,13,‡,§,*,
  13. K.W. Michael Siu1,2,‡

Article first published online: 22 APR 2009

DOI: 10.1002/ijc.24517

Issue

International Journal of Cancer

International Journal of Cancer

Volume 125, Issue 6, pages 1398–1406, 15 September 2009

Additional Information

How to Cite

Matta, A., Tripathi, S. C., DeSouza, L. V., Grigull, J., Kaur, J., Chauhan, S. S., Srivastava, A., Thakar, A., Shukla, N. K., Duggal, R., DattaGupta, S., Ralhan, R. and Michael Siu, K.W. (2009), Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma. Int. J. Cancer, 125: 1398–1406. doi: 10.1002/ijc.24517

Author Information

  1. 1

    Department of Chemistry, York University, Toronto, Ontario, Canada

  2. 2

    Centre for Research in Mass Spectrometry, York University, Toronto, Ontario, Canada

  3. 3

    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India

  4. 4

    Department of Mathematics and Statistics, York University, Toronto, Ontario, Canada

  5. 5

    Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India

  6. 6

    Department of Otorhinolaryngology, All India Institute of Medical Sciences, New Delhi, India

  7. 7

    Department of Surgery, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

  8. 8

    Department of Dental Surgery, All India Institute of Medical Sciences, New Delhi, India

  9. 9

    Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

  10. 10

    Joseph and Mildred Sonshine Family Centre for Head and Neck Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada

  11. 11

    Department of Otolaryngology – Head and Neck Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada

  12. 12

    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

  13. 13

    Department of Otolaryngology – Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada

  1. †

    The first two authors contributed equally to this study.

  2. ‡

    RR and KWMS are senior authors in this study.

  3. §

    Fax: +(416)736-5936.

*Centre for Research in Mass Spectrometry, Department of Chemistry, York University, 4700 Keele Street, Toronto, Ontario, Canada M3J 1P3

Publication History

  1. Issue published online: 14 JUL 2009
  2. Article first published online: 22 APR 2009
  3. Manuscript Accepted: 26 MAR 2009
  4. Manuscript Received: 16 JAN 2009

Funded by

  • Canadian Institutes of Health Research (CIHR)
  • Ontario Research and Development Challenge Fund
  • Applied Biosystems/MDS Analytical Technologies

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (793K)

References

  • 1
    Jemal A,Siegel R,Ward E,Hao Y,Xu J,Murray T,Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71–96.
    Direct Link:
  • 2
    Hunter KD,Parkinson EK,Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer 2005; 5: 127–35.
  • 3
    Warnakulasuriya KA,Ralhan R. Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco. J Oral Pathol Med 2007; 36: 63–77.
    Direct Link:
  • 4
    Warnakulasuriya S,Johnson NW,van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007; 36: 575–80.
    Direct Link:
  • 5
    Warnakulasuriya S,Reibel J,Bouquot J,Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008; 37: 127–33.
    Direct Link:
  • 6
    Brennan M,Migliorati CA,Lockhart PB,Wray D,Al-Hashimi I,Axéll T,Bruce AJ,Carpenter W,Eisenberg E,Epstein JB,Holmstrup P,Jontell M, et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: S19e1–12.
  • 7
    Valverde R,Edwards L,Regan L. Structure and function of KH domains. FEBS J 2008; 275: 2712–26.
    Direct Link:
  • 8
    Michelotti EF,Michelotti GA,Aronsohn AI,Levens D. Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol Cell Biol 1996; 16: 2350–60.
  • 9
    Bomsztyk K,Denisenko O,Ostrowski J. hnRNP K: one protein multiple processes. Bioessays 2004; 26: 629–38.
    Direct Link:
  • 10
    Lynch M,Chen L,Ravitz MJ,Mehtani S,Korenblat K,Pazin MJ,Schmidt EV. hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation. Mol Cell Biol 2005; 25: 6436–53.
  • 11
    Carpenter B,MacKay C,Alnabulsi A,MacKay M,Telfer C,Melvin WT,Murray GI. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta 2006; 1765: 85–100.
  • 12
    Evans JR,Mitchell SA,Spriggs KA,Ostrowski J,Bomsztyk K,Ostarek D,Willis AE. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 2003; 22: 8012–20.
  • 13
    Moumen A,Masterson P,O'Connor MJ,Jackson SP. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Cell 2005; 123: 1065–78.
  • 14
    Ostareck-Lederer A,Ostareck DH. Control of mRNA translation and stability in haematopoietic cells: the function of hnRNPs K and E1/E2. Biol Cell 2004; 96: 407–11.
  • 15
    Hatakeyama H,Kondo T,Fujii K,Nakanishi Y,Kato H,Fukuda S,Hirohashi S. Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics 2006; 6: 6300–16.
    Direct Link:
  • 16
    Pino I,Pío R,Toledo G,Zabalegui N,Vicent S,Rey N,Lozano MD,Torre W,García-Foncillas J,Montuenga LM. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer 2003; 41: 131–43.
  • 17
    Sun Y,Yi H,Zhang PF,Li MY,Li C,Li F,Peng F,Feng XP,Yang YX,Yang F,Xiao ZQ,Chen ZC. Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis. FEBS Lett 2007; 581: 131–9.
  • 18
    Carpenter B,McKay M,Dundas SR,Lawrie LC,Telfer C,Murray G. Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localized and is associated with poor prognosis in colorectal cancer. Br J Cancer 2006; 95: 921–7.
  • 19
    de Hoog CL,Foster LJ,Mann M. RNA and RNA binding proteins participate in early stages of cell spreading through spreading initiation centers. Cell 2004; 117: 649–62.
  • 20
    Inoue A,Sawata SY,Taira K,Wadhwa R. Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis. Proc Natl Acad Sci USA 2007; 104: 8983–8.
  • 21
    Mandal M,Vadlamudi R,Nguyen D,Wang RA,Costa L,Bagheri-Yarmand R,Mendelsohn J,Kumar R. Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. J Biol Chem 2001; 276: 9699–704.
  • 22
    Aman P,Panagopoulos I,Lassen C,Fioretos T,Mencinger M,Toresson H,Höglund M,Forster A,Rabbitts TH,Ron D,Mandahl N,Mitelman F. Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 1996; 37: 1–8.
  • 23
    Roychoudhury P,Chaudhuri K. Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma. Br J Cancer 2007; 97: 574–5.
  • 24
    Ralhan R,DeSouza LV,Matta A,Chandra Tripathi S,Ghanny S,Dattagupta S,Thakar A,Chauhan SS,Siu KW. iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. J Proteome Res 2009; 8: 300–9.
  • 25
    DeSouza LV,Taylor AM,Li W,Minkoff MS,Romaschin AD,Colgan TJ,Siu KW. Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues. J Proteome Res 2008; 7: 3525–34.
  • 26
    Ralhan R,DeSouza LV,Matta A,Chandra Tripathi S,Ghanny S,Datta Gupta S,Bahadur S,Siu KW. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol Cell Proteomics 2008; 7: 162–73.
  • 27
    Matta A,DeSouza LV,Shukla NK,Gupta SD,Ralhan R,Siu KW. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res 2008; 7: 2078–87.
  • 28
    Moskowitz CS,Pepe MS. Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome. Statist Med 2004; 23: 1555–1570.
    Direct Link:
  • 29
    Pepe MS. The statistical evaluation of medical tests for classification and prediction. Oxford University Press, Oxford; 2003.
  • 30
    Matta A,Bahadur S,Duggal R,Gupta SD,Ralhan R. Over-expression of 14–3-3zeta is an early event in oral cancer. BMC Cancer 2007; 2: 169.
  • 31
    Arora S,Matta A,Shukla NK,Deo SV,Ralhan R. Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog 2005; 42: 97–108.
    Direct Link:
  • 32
    Adolph D,Flach N,Mueller K,Ostareck DH,Ostareck-Lederer A. Deciphering the cross talk between hnRNP K and c-Src: the c-Src activation domain in hnRNP K is distinct from a second interaction site. Mol Cell Biol 2007; 27: 1758–70.
  • 33
    Naarmann IS,Harnisch C,Flach N,Kremmer E,Kühn H,Ostareck DH,Ostareck-Lederer A. mRNA silencing in human erythroid cell maturation: hnRNP K controls the expression of its regulator c-Src. J Biol Chem 2008; 283: 18461–72.
  • 34
    Ostrowski J,Bomsztyk K. Nuclear shift of hnRNP K protein in neoplasms and other states of enhanced cell proliferation. Br J Cancer 2003; 89: 1493–501.
  • 35
    Bomsztyk K,Denisenko O,Ostrowski J. hnRNP K: one protein multiple processes. Bioessays 2004; 26: 629–38.
    Direct Link:
  • 36
    He Y,Brown MA,Rothnagel JA,Saunders NA,Smith R. Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation. J Cell Sci 2005; 118: 3173–83.
  • 37
    Michael WM,Eder PS,Dreyfuss G. The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K protein. EMBO J 1997; 16: 3587–98.
  • 38
    Scully C,Porter S. ABC of oral health. Oral cancer. BMJ 2000; 321: 97–100.
  • 39
    Hunter KD,Parkinson EK,Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer 2005; 5: 127–35.
  • 40
    Chan JY,Huang SM,Liu ST,Huang CH. The transactivation domain of heterogeneous nuclear ribonucleoprotein K overlaps its nuclear shuttling domain. Int J Biochem Cell Biol 2008; 40: 2078–89.
  • 41
    Habelhah H,Shah K,Huang L,Ostareck-Lederer A,Burlingame AL,Shokat KM,Hentze MW,Ronai Z. ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat Cell Biol 2001; 3: 325–30.
  • 42
    Wolf D,Witte V,Clark P,Blume K,Lichtenheld MG,Baur AS. HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex. Cell Host Microbe 2008; 4: 398–408.
  • 43
    Skalweit A,Doller A,Huth A,Kähne T,Persson PB,Thiele BJ. Posttranscriptional control of renin synthesis: identification of proteins interacting with renin mRNA 3′-untranslated region. Circ Res 2003; 92: 419–27.
  • 44
    Collier B,Goobar-Larsson L,Sokolowski M,Schwartz S. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J Biol Chem 1998; 273: 22648–56.
  • 45
    Reimann I,Huth A,Thiele H,Thiele BJ. Suppression of 15-lipoxygenase synthesis by hnRNP E1 is dependent on repetitive nature of LOX mRNA 3′-UTR control element DICE. J Mol Biol 2002; 315: 965–74.
  • 46
    Lo WY,Lai CC,Hua CH,Tsai MH,Huang SY,Tsai CH,Tsai FJ. S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining. J Proteome Res 2007; 6: 2143–51.
View Full Article (HTML) Get PDF (793K)